Tandem Diabetes Care, Inc. (TNDM)

NGM – Real Time Price. Currency in USD

14.69

-0.08 (-0.54%)

At close: May 12, 2026, 4:00 PM EDT

09.05.2026

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care NASDAQ: TNDM reported record first-quarter pump shipments and sales for 2026, while reaffirming its full-year outlook as the diabetes technology company advances a shift toward pharmacy-channel reimbursement, expands direct international operations and prepares several product launches.

08.05.2026

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Tandem Diabetes Care, Inc. (TNDM) came out with a quarterly loss of $0.3 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to a loss of $0.67 per share a year ago.

07.05.2026

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

07.05.2026

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended March 31, 2026 and reaffirmed financial guidance for the year ending December 31, 2026. First Quarter 2026 Financial and Strategic Highlights Achieved record first quarter pump shipments, sales and gross margin: Shipments of more than 29,000 pumps worldwide, including 19,000 pumps in the United States Sales o.

29.04.2026

Tandem Diabetes Care Announces Upcoming Conference Presentations

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences: BofA Securities 2026 Health Care Conference on Tuesday, May 12, 2026 at 5:20 pm Eastern Time (2:20 pm Pacific Time), and Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 3:20 pm Eastern Time (12:20 pm Pacific Time). The presentations.

27.04.2026

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.

02.04.2026

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, plans to release its first quarter 2026 results after the financial markets close on Thursday, May 7, 2026. The Company will hold a conference call and simultaneous webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time), to discuss its first quarter 2026 financial and operating results. A live webcast of the call will be available on Tandem Diabetes.

Videos

No Data

There is no data to display

Press releases

07.05.2026

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

27.04.2026

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

SAN DIEGO--(BUSINESS WIRE)---- $TNDM #diabetes--FDA clears Tandem Diabetes Care's Control-IQ+ automated insulin delivery technology for use in pregnancy for people with type 1 diabetes.

27.03.2026

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

LOS ANGELES, March 27, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Tandem Diabetes Care, Inc. , (“ Tandem " or the "Company") ( NASDAQ:TNDM ) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.

04.03.2026

Tandem Mobi Now Compatible with Android Smartphones

SAN DIEGO--(BUSINESS WIRE)-- #TandemDiabetes--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that Tandem Mobi, the world's smallest, durable automated insulin delivery system,1 can now be used with compatible Android smartphones in the U.S. via the Tandem Mobi mobile app. "By expanding to Android, we're broadening our reach to bring the benefits of Tandem Mobi to even more people living with diabetes," said John Sheridan, president and chief.

Tandem Diabetes Care, Inc. (TNDM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Videos

No Data

Press releases

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Mobi Now Compatible with Android Smartphones

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Videos

No Data

Press releases

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Mobi Now Compatible with Android Smartphones

Search stocks

Tandem Diabetes Care, Inc. (TNDM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Videos

No Data

Press releases

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Mobi Now Compatible with Android Smartphones

Tandem Diabetes Care Q1 Earnings Call Highlights

Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates

Compared to Estimates, Tandem Diabetes Care (TNDM) Q1 Earnings: A Look at Key Metrics

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care Announces Upcoming Conference Presentations

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care to Announce First Quarter 2026 Financial Results on May 7, 2026

Videos

No Data

Press releases

Tandem Diabetes Care Announces First Quarter 2026 Financial Results

Tandem Diabetes Care's Control-IQ+ Automated Insulin Delivery Technology Now FDA Cleared for Pregnancy in Type 1 Diabetes

Tandem Diabetes Care, Inc. Investigated by the Portnoy Law Firm

Tandem Mobi Now Compatible with Android Smartphones